Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00131391
Status:
TERMINATED
Last Update Posted:
2015-04-03
First Post:
2005-08-16
Brief Title:
A Study of MK0364 in Obese Patients 0364-014
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A 2-Year Study 1-Year Weight Loss Followed by 1-Year Prevention of Weight Regain to Assess the Safety Tolerability and Efficacy of Taranabant MK0364 in Obese Patients Followed by a 1-Year Extension
Status:
TERMINATED
Status Verified Date:
2015-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
The overall profile does not support development for obesity
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A worldwide study in obese patients to assess the efficacy safety and tolerability of an investigational drug
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2005_034 | None | None | None |